{
    "id": 88,
    "premise": "none",
    "hypothesis": "PARP inhibitors not appropriate for this patient.",
    "label": "entailment",
    "explanation": "Patient does not have BRCA mutation.\nOlaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC.",
    "results": {
        "semantic validity": true,
        "premise": null,
        "hypothesis": "PARP inhibitors not appropriate for this patient.",
        "refined explanation": "Patient does not have BRCA mutation.\nOlaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC.\nPARP inhibitors are only appropriate for patients with a BRCA mutation.\nIf a patient does not have a BRCA mutation, then PARP inhibitors are not appropriate for them.",
        "refined iteration": 2,
        "history explanation": [
            "0 iteration: Patient does not have BRCA mutation.\nOlaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC.",
            "1 iteration: Patient does not have BRCA mutation.\nOlaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC.\nPARP inhibitors are only appropriate for patients with a BRCA mutation.",
            "2 iteration: Patient does not have BRCA mutation.\nOlaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC.\nPARP inhibitors are only appropriate for patients with a BRCA mutation.\nIf a patient does not have a BRCA mutation, then PARP inhibitors are not appropriate for them."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: True"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 states that a patient does not have a BRCA mutation. *)\\n(* This implies that the patient is not eligible for treatment with licensed PARP inhibitors like Olaparib and Talazoparib, which are for BRCA-mutated patients. *)\\n(* Therefore, PARP inhibitors are not appropriate for this patient. *)\\nthen have \"\u00acAppropriateFor x y\" sledgehammer', 'solving time': 105.08252549171448, 'proof tactics': [], 'code': 'theory clinical_88_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  BRCAMutation :: \"entity \u21d2 bool\"\\n  Have :: \"entity \u21d2 entity \u21d2 bool\"\\n  Olaparib :: \"entity \u21d2 bool\"\\n  Talazoparib :: \"entity \u21d2 bool\"\\n  LicensedPARPInhibitor :: \"entity \u21d2 bool\"\\n  BRCAMutated :: \"entity \u21d2 bool\"\\n  HER2Negative :: \"entity \u21d2 bool\"\\n  AdvancedBC :: \"entity \u21d2 bool\"\\n  MetastaticBC :: \"entity \u21d2 bool\"\\n  TreatmentFor :: \"entity \u21d2 entity \u21d2 entity \u21d2 bool\"\\n  PARPInhibitor :: \"entity \u21d2 bool\"\\n  AppropriateFor :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Patient does not have BRCA mutation *)\\naxiomatization where\\n  explanation_1: \"\u2200x y. Patient x \u2227 BRCAMutation y \u27f6 \u00acHave x y\"\\n\\n(* Explanation 2: Olaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z. (Olaparib x \u2228 Talazoparib x) \u2227 LicensedPARPInhibitor x \u2227 Patient y \u2227 BRCAMutated y \u2227 HER2Negative y \u2227 (AdvancedBC z \u2228 MetastaticBC z) \u27f6 TreatmentFor x y z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitor x \u2227 Patient y\"\\n  (* Hypothesis: PARP inhibitors not appropriate for this patient *)\\n  shows \"\u2200x y. PARPInhibitor x \u2227 Patient y \u27f6 \u00acAppropriateFor x y\"\\nproof -\\n  (* From the premise, we have known information about the PARP inhibitor and the patient. *)\\n  from asm have \"PARPInhibitor x \u2227 Patient y\" <ATP>\\n  (* Explanation 1 states that a patient does not have a BRCA mutation. *)\\n  (* This implies that the patient is not eligible for treatment with licensed PARP inhibitors like Olaparib and Talazoparib, which are for BRCA-mutated patients. *)\\n  (* Therefore, PARP inhibitors are not appropriate for this patient. *)\\n  then have \"\u00acAppropriateFor x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Patient has BRCA mutation (from Explanatory Sentence 1)\\nB: Olaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nNot(A)\\nNot(Patient has BRCA mutation)\\n--------\\nImplies(A, B)\\nImplies(Patient has BRCA mutation, Olaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC)\\n--------\\n\\nDerived Implications:\\nImplies(B, Not(A))\\nImplies(Olaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC, Not(Patient has BRCA mutation))\\n--------\\nImplies(A, Not(B))\\nImplies(Patient has BRCA mutation, Not(Olaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC))\\n--------\\n'}",
            "1 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 states that patients do not have BRCA mutation. *)\\n(* Explanation 3 states that PARP inhibitors are only appropriate for patients with a BRCA mutation. *)\\n(* Since the patient does not have a BRCA mutation, we can infer that PARP inhibitors are not appropriate for this patient. *)\\nthen have \"\u00acBRCAMutation y\" sledgehammer', 'solving time': 104.25838375091553, 'proof tactics': [], 'code': 'theory clinical_88_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  BRCAMutation :: \"entity \u21d2 bool\"\\n  Have :: \"entity \u21d2 entity \u21d2 bool\"\\n  Olaparib :: \"entity \u21d2 bool\"\\n  Talazoparib :: \"entity \u21d2 bool\"\\n  PARPInhibitor :: \"entity \u21d2 bool\"\\n  Licensed :: \"entity \u21d2 bool\"\\n  BRCAMutated :: \"entity \u21d2 bool\"\\n  HER2Negative :: \"entity \u21d2 bool\"\\n  AdvancedBC :: \"entity \u21d2 bool\"\\n  MetastaticBC :: \"entity \u21d2 bool\"\\n  TreatmentFor :: \"entity \u21d2 entity \u21d2 bool\"\\n  AppropriateFor :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Patient does not have BRCA mutation *)\\naxiomatization where\\n  explanation_1: \"\u2200x y. Patient x \u2227 BRCAMutation y \u27f6 \u00acHave x y\"\\n\\n(* Explanation 2: Olaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z. (Olaparib x \u2228 Talazoparib x) \u2227 PARPInhibitor x \u2227 Licensed x \u2227 Patient y \u2227 BRCAMutated y \u2227 HER2Negative y \u2227 (AdvancedBC z \u2228 MetastaticBC z) \u27f6 TreatmentFor x y\"\\n\\n(* Explanation 3: PARP inhibitors are only appropriate for patients with a BRCA mutation *)\\naxiomatization where\\n  explanation_3: \"\u2200x y. PARPInhibitor x \u2227 Patient y \u2227 BRCAMutation y \u27f6 AppropriateFor x y\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitor x \u2227 Patient y\"\\n  (* Hypothesis: PARP inhibitors not appropriate for this patient *)\\n  shows \"\u2200x y. PARPInhibitor x \u2227 Patient y \u27f6 \u00acAppropriateFor x y\"\\nproof -\\n  (* From the premise, we have known information about PARP inhibitors and the patient. *)\\n  from asm have \"PARPInhibitor x \u2227 Patient y\" <ATP>\\n  (* Explanation 1 states that patients do not have BRCA mutation. *)\\n  (* Explanation 3 states that PARP inhibitors are only appropriate for patients with a BRCA mutation. *)\\n  (* Since the patient does not have a BRCA mutation, we can infer that PARP inhibitors are not appropriate for this patient. *)\\n  then have \"\u00acBRCAMutation y\" <ATP>\\n  (* Using explanation 3, we can conclude that PARP inhibitors are not appropriate for this patient. *)\\n  then have \"\u00acAppropriateFor x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Patient has BRCA mutation (from Explanatory Sentence 1)\\nB: Olaparib and talazoparib are appropriate treatments (from Explanatory Sentence 2)\\nC: PARP inhibitors are appropriate (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nNot(A)\\nNot(Patient has BRCA mutation)\\n--------\\nImplies(A, C)\\nImplies(Patient has BRCA mutation, PARP inhibitors are appropriate)\\n--------\\nImplies(C, B)\\nImplies(PARP inhibitors are appropriate, Olaparib and talazoparib are appropriate treatments)\\n--------\\n\\nDerived Implications:\\nImplies(Not(B), Not(A))\\nImplies(Not(Olaparib and talazoparib are appropriate treatments), Not(Patient has BRCA mutation))\\n--------\\nImplies(A, Not(C))\\nImplies(Patient has BRCA mutation, Not(PARP inhibitors are appropriate))\\n--------\\nImplies(A, Not(B))\\nImplies(Patient has BRCA mutation, Not(Olaparib and talazoparib are appropriate treatments))\\n--------\\nImplies(B, Not(A))\\nImplies(Olaparib and talazoparib are appropriate treatments, Not(Patient has BRCA mutation))\\n--------\\nImplies(A, B)\\nImplies(Patient has BRCA mutation, Olaparib and talazoparib are appropriate treatments)\\n--------\\nImplies(C, Not(A))\\nImplies(PARP inhibitors are appropriate, Not(Patient has BRCA mutation))\\n--------\\n'}",
            "2 iteration: {'syntactic validity': True, 'error code': '', 'solving time': 6.886286497116089, 'proof tactics': ['Sledgehammering...', 'zipperposition found a proof...', 'cvc4 found a proof...', 'e found a proof...', 'vampire found a proof...', 'zipperposition: Try this: using explanation_1 explanation_4 by blast (1 ms)', 'e: Try this: using explanation_1 explanation_4 by presburger (2 ms)', 'cvc4: Found duplicate proof', 'vampire: Found duplicate proof', 'Done'], 'code': 'theory clinical_88_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  BRCAMutation :: \"entity \u21d2 bool\"\\n  Have :: \"entity \u21d2 entity \u21d2 bool\"\\n  Olaparib :: \"entity \u21d2 bool\"\\n  Talazoparib :: \"entity \u21d2 bool\"\\n  PARPInhibitor :: \"entity \u21d2 bool\"\\n  BRCAMutated :: \"entity \u21d2 bool\"\\n  HER2Negative :: \"entity \u21d2 bool\"\\n  AdvancedBC :: \"entity \u21d2 bool\"\\n  MetastaticBC :: \"entity \u21d2 bool\"\\n  LicensedForTreatment :: \"entity \u21d2 entity \u21d2 bool\"\\n  AppropriateFor :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Patient does not have BRCA mutation *)\\naxiomatization where\\n  explanation_1: \"\u2200x y. Patient x \u2227 BRCAMutation y \u27f6 \u00acHave x y\"\\n\\n(* Explanation 2: Olaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z. (Olaparib x \u2228 Talazoparib x) \u2227 PARPInhibitor x \u2227 Patient y \u2227 BRCAMutated y \u2227 HER2Negative y \u2227 (AdvancedBC y \u2228 MetastaticBC y) \u27f6 LicensedForTreatment x y\"\\n\\n(* Explanation 3: PARP inhibitors are only appropriate for patients with a BRCA mutation *)\\naxiomatization where\\n  explanation_3: \"\u2200x y. PARPInhibitor x \u2227 Patient y \u2227 BRCAMutation y \u27f6 AppropriateFor x y\"\\n\\n(* Explanation 4: If a patient does not have a BRCA mutation, then PARP inhibitors are not appropriate for them *)\\naxiomatization where\\n  explanation_4: \"\u2200x y. (Patient x \u2227 BRCAMutation y \u27f6 \u00acHave x y) \u27f6 (\u2200z. PARPInhibitor z \u27f6 \u00acAppropriateFor z x)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitor x \u2227 Patient y\"\\n  (* Hypothesis: PARP inhibitors not appropriate for this patient *)\\n  shows \"\u2200x y. PARPInhibitor x \u2227 Patient y \u27f6 \u00acAppropriateFor x y\"\\nproof -\\n  (* From the premise, we have known information about the PARP inhibitor and the patient. *)\\n  from asm have \"PARPInhibitor x \u2227 Patient y\" <ATP>\\n  (* Explanation 1 states that a patient does not have a BRCA mutation. *)\\n  (* Explanation 4 provides a logical relation that if a patient does not have a BRCA mutation, then PARP inhibitors are not appropriate for them. *)\\n  (* We can use this to infer that PARP inhibitors are not appropriate for this patient. *)\\n  from explanation_1 have \"\u2200x y. Patient x \u2227 BRCAMutation y \u27f6 \u00acHave x y\" <ATP>\\n  then have \"\u2200x. Patient x \u27f6 \u00acBRCAMutation x\" <ATP>\\n  from this and explanation_4 have \"\u2200x y. (Patient x \u2227 \u00acBRCAMutation x) \u27f6 (\u2200z. PARPInhibitor z \u27f6 \u00acAppropriateFor z x)\" <ATP>\\n  then have \"\u2200x y. PARPInhibitor x \u2227 Patient y \u27f6 \u00acAppropriateFor x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Patient has BRCA mutation (from Explanatory Sentence 1)\\nB: Olaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC (from Explanatory Sentence 2)\\nC: PARP inhibitors are appropriate for patients (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nNot(A)\\nNot(Patient has BRCA mutation)\\n--------\\nImplies(Not(A), Not(C))\\nImplies(Not(Patient has BRCA mutation), Not(PARP inhibitors are appropriate for patients))\\n--------\\nImplies(A, C)\\nImplies(Patient has BRCA mutation, PARP inhibitors are appropriate for patients)\\n--------\\n\\nDerived Implications:\\nImplies(C, Not(C))\\nImplies(PARP inhibitors are appropriate for patients, Not(PARP inhibitors are appropriate for patients))\\n--------\\nImplies(C, Not(A))\\nImplies(PARP inhibitors are appropriate for patients, Not(Patient has BRCA mutation))\\n--------\\nImplies(A, Not(C))\\nImplies(Patient has BRCA mutation, Not(PARP inhibitors are appropriate for patients))\\n--------\\n'}"
        ]
    }
}